ECSP18039827A - Anticuerpo que neutraliza el virus respiratorio sincitial humano - Google Patents
Anticuerpo que neutraliza el virus respiratorio sincitial humanoInfo
- Publication number
- ECSP18039827A ECSP18039827A ECIEPI201839827A ECPI201839827A ECSP18039827A EC SP18039827 A ECSP18039827 A EC SP18039827A EC IEPI201839827 A ECIEPI201839827 A EC IEPI201839827A EC PI201839827 A ECPI201839827 A EC PI201839827A EC SP18039827 A ECSP18039827 A EC SP18039827A
- Authority
- EC
- Ecuador
- Prior art keywords
- neutralizes
- antibody
- human
- antibodies
- respiratory virus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a anticuerpos monoclonales que tienen altos títulos neutralizantes anti-VRS. La invención proporciona además ácidos nucleicos aislados que codifican los anticuerpos de la invención y células huésped transformadas con los mismos. La invención proporciona aún además métodos de diagnóstico, profilácticos y terapéuticos que emplean los anticuerpos y ácidos nucleicos de la invención, particularmente como un agente de inmunoterapia pasiva en lactantes y ancianos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562247841P | 2015-10-29 | 2015-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP18039827A true ECSP18039827A (es) | 2018-07-31 |
Family
ID=61159870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201839827A ECSP18039827A (es) | 2015-10-29 | 2018-05-24 | Anticuerpo que neutraliza el virus respiratorio sincitial humano |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR106471A1 (es) |
| EC (1) | ECSP18039827A (es) |
-
2016
- 2016-10-25 AR ARP160103254A patent/AR106471A1/es unknown
-
2018
- 2018-05-24 EC ECIEPI201839827A patent/ECSP18039827A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR106471A1 (es) | 2018-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201800052A (es) | Anticuerpos que neutraliza el virus respiratorio sincitial humano | |
| JOP20200192A1 (ar) | أجسام مضادة لـ tigit | |
| MX2015013065A (es) | Proteinas f de rsv de prefusion y su uso. | |
| PH12017500949A1 (en) | Human antibodies to influenza hemagglutinin | |
| JOP20190055A1 (ar) | أجسام مضادة ضد cd27 | |
| UY36006A (es) | Construcciones de proteína uspa2 y usos de las mismas. | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| UA116999C2 (uk) | Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить | |
| MX2015014751A (es) | Composiciones y metodos para el tratamiento de la inmunodeficiencia. | |
| BR112018003526A2 (pt) | métodos de tratamento de doenças inflamatórias | |
| AR100944A1 (es) | ANTICUERPOS ANTAGONISTAS DE INTERFERÓN a Y w | |
| MX2023006415A (es) | Anticuerpos, usos y metodos. | |
| PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| UA116697C2 (uk) | Композиція для запобігання зараженню видами роду mycoplasma | |
| WO2013173256A3 (en) | New and improved influenza vaccines | |
| ECSP18039827A (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
| PH12017500928A1 (en) | A rabies composition comprising pika adjuvant | |
| WO2014188212A3 (en) | Treatment and prevention of malaria | |
| EA201891048A1 (ru) | Антитело, нейтрализующее респираторно-синцитиальный вирус человека | |
| MX358262B (es) | Vacuna epitopica a partir de un epitope inmunogenico de la neuraminidasa del virus de la influenza ah1n1 y metodo para la obtencion del mismo. | |
| AR099553A1 (es) | Construcciones de proteína uspa2 y usos de las mismas |